CARG 2020
Alternative Names: CARG-2020Latest Information Update: 28 Nov 2024
At a glance
- Originator CaroGen
- Developer CaroGen; Wayne State University
- Class Antineoplastics; Cytokines; Gene therapies; Immunotherapies; Oncolytic viruses; Proteins; RNA
- Mechanism of Action B7-H1 antigen expression inhibitors; Cell death stimulants; Immunologic cytotoxicity; Interleukin-12 expression stimulants; Interleukin-17 receptor expression stimulants; RNA interference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Colorectal cancer
- No development reported Ovarian cancer; Peritoneal cancer
Most Recent Events
- 28 Nov 2024 No recent reports of development identified for preclinical development in Ovarian-cancer in USA (Parenteral)
- 28 Nov 2024 No recent reports of development identified for preclinical development in Peritoneal-cancer in USA (Parenteral)
- 04 Jun 2021 Preclinical trials in Colorectal cancer in USA (Intratumoural) before June 2021